4 employees
Trigemina develops non-opiate drug formulations and delivery systems for pain therapy.
2006
$8M
from 1 investors over 1 rounds
Trigemina, Inc. raised $8M on April 14, 2014
Investors: Aurus S.A. Gestión de Inversiones